Historical record - last NADAC effective date: 3/23/2016

Product Information

SILENOR 3 MG TABLET is a brand product labeled by Currax Pharmaceuticals LLC, priced at $11.9361 per EA under NDC 42847010303. Its NADAC has been published 163 times since Nov 28, 2013.

FDA first approved this application on Mar 17, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the doxepin hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

SILENOR 3 MG TABLET

doxepin hydrochloride
$11.9361per EA
High Outlier

Strength

3 mg/1

NDC

42847010303

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

3/23/2016

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA022036

FDA Approved

3/17/2010

TE Code

AB

On Market Since

8/1/2010

Pharmacological Classes

Price Statistics

The NADAC for SILENOR 3 MG TABLET has been published 163 times since Nov 28, 2013, and over the history we have for it it has risen 113.5%. The table below summarizes its recorded NADAC range and movement.

Current price$11.9361 per EA
All-time high$11.9361 (Jan 4, 2017)
All-time low$5.5899 (Nov 28, 2013)
Median price$10.1984
Average price$10.3737
Largest weekly change+40.0% (Apr 9, 2014)
Weeks tracked163
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+113.5%

Last surveyed Jan 4, 2017 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of SILENOR 3 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SILENOR 3 MG TABLET, manufactured by Currax Pharmaceuticals LLC, is $11.9361 per EA (NDC 42847010303), effective Jan 4, 2017.

How has the price of SILENOR 3 MG TABLET changed over time?

Over the history we have for it, the NADAC for SILENOR 3 MG TABLET has risen 113.5%. It has been tracked across 163 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SILENOR 3 MG TABLET?

Since Nov 28, 2013, the NADAC for SILENOR 3 MG TABLET has ranged from a low of $5.5899 (Nov 28, 2013) to a high of $11.9361 (Jan 4, 2017), with a median of $10.1984 per EA.

Are there cheaper alternatives to SILENOR 3 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DOXEPIN HCL 3 MG TABLET, is $1.3644 per EA — about 89% below SILENOR 3 MG TABLET.

Who manufactures SILENOR 3 MG TABLET?

SILENOR 3 MG TABLET (NDC 42847010303) is labeled by Currax Pharmaceuticals LLC, and CMS classifies it as a brand product.